HUP0200791A2 - 5-Klór-2-metoxi-N-(2-(4-metoxi-3-metil-amino-tio-karbonil-amino-szulfonil-fenil)-etil)-benzamid nátriumsójának kristályos formái - Google Patents
5-Klór-2-metoxi-N-(2-(4-metoxi-3-metil-amino-tio-karbonil-amino-szulfonil-fenil)-etil)-benzamid nátriumsójának kristályos formáiInfo
- Publication number
- HUP0200791A2 HUP0200791A2 HU0200791A HUP0200791A HUP0200791A2 HU P0200791 A2 HUP0200791 A2 HU P0200791A2 HU 0200791 A HU0200791 A HU 0200791A HU P0200791 A HUP0200791 A HU P0200791A HU P0200791 A2 HUP0200791 A2 HU P0200791A2
- Authority
- HU
- Hungary
- Prior art keywords
- methoxy
- sulfonylphenyl
- benzamide
- chloro
- ethyl
- Prior art date
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 2
- 159000000000 sodium salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19917233A DE19917233A1 (de) | 1999-04-16 | 1999-04-16 | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
| PCT/EP2000/002984 WO2000063167A1 (en) | 1999-04-16 | 2000-04-04 | Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0200791A2 true HUP0200791A2 (hu) | 2002-07-29 |
| HUP0200791A3 HUP0200791A3 (en) | 2005-04-28 |
| HU229082B1 HU229082B1 (hu) | 2013-07-29 |
Family
ID=7904803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200791A HU229082B1 (hu) | 1999-04-16 | 2000-04-04 | 5-Klór-2-metoxi-N-(2-(4-metoxi-3-metil-amino-tiokarbonil-amino-szulfonil-fenil)-etil)-benzamid nátriumsójának 3-as kristály formája |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6723751B1 (hu) |
| EP (2) | EP1173418B1 (hu) |
| JP (1) | JP4662640B2 (hu) |
| KR (1) | KR100700302B1 (hu) |
| CN (1) | CN1168712C (hu) |
| AR (1) | AR023479A1 (hu) |
| AT (2) | ATE414059T1 (hu) |
| AU (1) | AU773246B2 (hu) |
| BR (1) | BR0010658A (hu) |
| CA (1) | CA2370388C (hu) |
| CZ (1) | CZ302459B6 (hu) |
| DE (3) | DE19917233A1 (hu) |
| DK (1) | DK1173418T3 (hu) |
| EE (1) | EE04612B1 (hu) |
| ES (1) | ES2251996T3 (hu) |
| HK (1) | HK1046270B (hu) |
| HR (1) | HRP20010744B1 (hu) |
| HU (1) | HU229082B1 (hu) |
| IL (2) | IL145921A0 (hu) |
| ME (1) | MEP55708A (hu) |
| MX (1) | MXPA01010275A (hu) |
| MY (1) | MY122588A (hu) |
| NO (1) | NO327798B1 (hu) |
| NZ (1) | NZ514788A (hu) |
| PL (1) | PL203809B1 (hu) |
| RS (1) | RS50916B (hu) |
| RU (1) | RU2235089C2 (hu) |
| SI (1) | SI1173418T1 (hu) |
| SK (1) | SK287175B6 (hu) |
| TR (2) | TR200102993T2 (hu) |
| TW (1) | TWI276622B (hu) |
| WO (1) | WO2000063167A1 (hu) |
| ZA (1) | ZA200108400B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ542852A (en) * | 2003-03-17 | 2008-09-26 | Japan Tobacco Inc | Pharmaceutical compositions of CETP inhibitors |
| TWI393560B (zh) * | 2003-05-02 | 2013-04-21 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2098069T3 (es) * | 1993-02-23 | 1997-04-16 | Hoechst Ag | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos. |
| DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AU762832B2 (en) * | 1998-09-10 | 2003-07-03 | Sanofi-Aventis Deutschland Gmbh | Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
-
1999
- 1999-04-16 DE DE19917233A patent/DE19917233A1/de not_active Withdrawn
-
2000
- 2000-04-04 DE DE60024431T patent/DE60024431T2/de not_active Expired - Lifetime
- 2000-04-04 ES ES00926805T patent/ES2251996T3/es not_active Expired - Lifetime
- 2000-04-04 MX MXPA01010275A patent/MXPA01010275A/es active IP Right Grant
- 2000-04-04 SI SI200030775T patent/SI1173418T1/sl unknown
- 2000-04-04 IL IL14592100A patent/IL145921A0/xx active IP Right Grant
- 2000-04-04 RS YUP-720/01A patent/RS50916B/sr unknown
- 2000-04-04 CA CA002370388A patent/CA2370388C/en not_active Expired - Fee Related
- 2000-04-04 CN CNB008063184A patent/CN1168712C/zh not_active Expired - Fee Related
- 2000-04-04 DK DK00926805T patent/DK1173418T3/da active
- 2000-04-04 AT AT05024254T patent/ATE414059T1/de not_active IP Right Cessation
- 2000-04-04 AU AU45428/00A patent/AU773246B2/en not_active Ceased
- 2000-04-04 JP JP2000612263A patent/JP4662640B2/ja not_active Expired - Fee Related
- 2000-04-04 TR TR2001/02993T patent/TR200102993T2/xx unknown
- 2000-04-04 KR KR1020017013220A patent/KR100700302B1/ko not_active IP Right Cessation
- 2000-04-04 ME MEP-557/08A patent/MEP55708A/xx unknown
- 2000-04-04 BR BR0010658-5A patent/BR0010658A/pt not_active IP Right Cessation
- 2000-04-04 WO PCT/EP2000/002984 patent/WO2000063167A1/en active IP Right Grant
- 2000-04-04 CZ CZ20013672A patent/CZ302459B6/cs not_active IP Right Cessation
- 2000-04-04 RU RU2001130886/04A patent/RU2235089C2/ru not_active IP Right Cessation
- 2000-04-04 PL PL351245A patent/PL203809B1/pl unknown
- 2000-04-04 EE EEP200100532A patent/EE04612B1/xx not_active IP Right Cessation
- 2000-04-04 DE DE60040811T patent/DE60040811D1/de not_active Expired - Lifetime
- 2000-04-04 HU HU0200791A patent/HU229082B1/hu not_active IP Right Cessation
- 2000-04-04 EP EP00926805A patent/EP1173418B1/en not_active Expired - Lifetime
- 2000-04-04 NZ NZ514788A patent/NZ514788A/xx not_active IP Right Cessation
- 2000-04-04 SK SK1458-2001A patent/SK287175B6/sk not_active IP Right Cessation
- 2000-04-04 AT AT00926805T patent/ATE311364T1/de active
- 2000-04-04 EP EP05024254A patent/EP1637519B1/en not_active Expired - Lifetime
- 2000-04-04 TR TR2005/01142T patent/TR200501142T2/xx unknown
- 2000-04-13 AR ARP000101712A patent/AR023479A1/es not_active Application Discontinuation
- 2000-04-14 US US09/549,538 patent/US6723751B1/en not_active Expired - Lifetime
- 2000-04-14 MY MYPI20001609A patent/MY122588A/en unknown
- 2000-05-10 TW TW089106840A patent/TWI276622B/zh not_active IP Right Cessation
-
2001
- 2001-10-12 ZA ZA200108400A patent/ZA200108400B/xx unknown
- 2001-10-14 IL IL145921A patent/IL145921A/en not_active IP Right Cessation
- 2001-10-15 NO NO20015014A patent/NO327798B1/no not_active IP Right Cessation
- 2001-10-15 HR HR20010744A patent/HRP20010744B1/xx not_active IP Right Cessation
-
2002
- 2002-10-30 HK HK02107874.4A patent/HK1046270B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202536A3 (en) | Crystals of the sodium salt of pravastatin | |
| HK1026699A1 (en) | Crystalline form of omeprazole sodium salt | |
| HK1064035A1 (en) | Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds | |
| NO20016319D0 (no) | VLA-4 inhibitor-forbindelser | |
| HK1041259A1 (en) | Novel crystalline form of the potassium salt of (s)- omeprazole | |
| EE200100135A (et) | EtO2C-CH2-(R)Cgl-Aze-Pab-OH kristalsed vormid | |
| IL159861A0 (en) | Crystalline forms of fluvastatin sodium | |
| AU1234002A (en) | Crystalline forms of venlafaxine hydrochloride | |
| IL150187A0 (en) | Novel forms of pravastatin sodium | |
| HUP0200791A3 (en) | Crystalline forms of the sodium salt of 5-chloro-2-methoxy-n-(2-(4-methoxy-3-methyl aminothio carbonylamino sulfonylphenyl)ethyl)benzamide | |
| HK1035535A1 (en) | Crystalline forms of osanetant | |
| PL345542A1 (en) | Novel salts of n-tert-butylhydroxylamine | |
| IL150245A0 (en) | Process for the preparation of sodium salts of statins | |
| HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
| FR2826662B1 (fr) | Procede de preparation d'un sel de polyaniline | |
| SI1102747T1 (en) | Crystalline forms of osanetant | |
| GB2376233B (en) | Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns | |
| EP1310505A4 (en) | AMINE SALT OF LIGNANE COMPOUND |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |